These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24836395)

  • 41. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
    Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
    Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
    Wiednig M; Beham-Schmid C; Kranzelbinder B; Aberer E
    Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
    Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J
    Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
    Valent P; Horny HP; Triggiani M; Arock M
    Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-allergic, mastocytosis-associated rhinitis.
    Dollner R; Taraldsrud E; Iversen K; Osnes T; Kristensen B; Kramer MF
    Clin Exp Allergy; 2013 Apr; 43(4):406-12. PubMed ID: 23517036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single-center experience.
    Lange M; Zawadzka A; Schrörs S; Słomka J; Ługowska-Umer H; Nedoszytko B; Nowicki R
    Postepy Dermatol Alergol; 2017 Aug; 34(4):306-312. PubMed ID: 28951704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How much specific is the association between hymenoptera venom allergy and mastocytosis?
    Bonadonna P; Zanotti R; Pagani M; Caruso B; Perbellini O; Colarossi S; Olivieri E; Dama A; Schiappoli M; Senna G; Antico A; Passalacqua G
    Allergy; 2009 Sep; 64(9):1379-82. PubMed ID: 19627274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
    Sonneck K; Florian S; Müllauer L; Wimazal F; Födinger M; Sperr WR; Valent P
    Int Arch Allergy Immunol; 2007; 142(2):158-64. PubMed ID: 17057414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB
    Dermatology; 2013; 226(3):233-7. PubMed ID: 23774045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.
    Corless CL; Harrell P; Lacouture M; Bainbridge T; Le C; Gatter K; White C; Granter S; Heinrich MC
    J Mol Diagn; 2006 Nov; 8(5):604-12. PubMed ID: 17065430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mastocytosis : Clinical aspects, diagnostics, therapy].
    Lippert U
    Hautarzt; 2017 Jan; 68(1):67-75. PubMed ID: 27995272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
    Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
    J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous mastocytosis, problems of clinical diagnosis of four cases.
    Pătraşcu V; Enache AO; Ciurea RN; Georgescu CC; Vîlcea AM; Stoica LE; Ciurea ME
    Rom J Morphol Embryol; 2014; 55(3):965-71. PubMed ID: 25329129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
    Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny HP; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3010-3020. PubMed ID: 37572755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.